Introducing Semaglutide and Tirzepatide: The Future of Weight Loss Solutions Focused Solely on Your Wellness Journey.
Many individuals embarking on a weight loss journey often encounter issues such as loose skin and the emergence of wrinkles. However, at our clinic, we are dedicated to devising a comprehensive plan that not only facilitates weight loss but also fosters a rejuvenated and youthful appearance. Our aim is to promote a combination of weight loss and a more youthful appearance.
My name is Dr. Dale Knox. I have been doing Weight loss in my family practice since 2014 using the same medication. I now have over 5000 patients who have used the GLP one therapy successfully. When I average all comers the average body weight loss is 53 pounds. I have 15 people who have lost 80 pounds. I have three people who have lost 100 pounds. I have one gentleman who has lost 150 pounds. It is remarkably successful program. I am board certified in emergency medicine and have my own private practice over 30 years.
The current medications that we use include Semaglutide and Tirzepatide and are remarkably capable medications to help with weight loss. This is a weekly subcutaneous injection given by the individual at their home. If you do not want to give yourself an injection you can come into the clinic.
There is follow up every three months to verify Quality of care. In addition to body weight loss the New York Times printed an article August 8 that confirmed additional incentive that included 20% risk reduction in both heart attack and stroke. This was confirmed in the medical journal New England Journal of medicine. If you are having difficulty losing weight on your own please come by the clinic and we can help. I have had extensive experience in using the current medications. I can help.
Clinical trials by the U.S. Food & Drug Administration showed patients on this amazing drug lost an average ~15% of their body weight or ~35lbs, but with longer-term yields showed results in a weight loss of 30%!
On your service when you sign up for our newsletter.